Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Modern Pathology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.2010.198PMID 21057458PMCID PMC4416483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer subtypes and the risk of local and regional relapse.

  2010cited by this paper
• Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer

  2010cited by this paper
• Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes

  2009cited by this paper
• Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression

  2009cited by this paper
• Gene-expression signatures in breast cancer.

  2009cited by this paper
• Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically

  2009cited by this paper
• The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression

  2009cited by this paper
• Triple-Negative Breast Cancer: Risk Factors to Potential Targets

  2008cited by this paper
• Telomere DNA Content Predicts Breast Cancer–Free Survival Interval

  2007cited by this paper
• Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

  2007cited by this paper
• Telomere content correlates with stage and prognosis in breast cancer

  2006cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• Telomere maintenance and tumorigenesis: an "ALT"ernative road.

  2005cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis

  2004cited by this paper
• Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma.

  2004cited by this paper
• In situ analyses of genome instability in breast cancer

  2004cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Gene-expression signatures in breast cancer.

  2003cited by this paper
• Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

  2003cited by this paper
• Alternative lengthening of telomeres, telomerase, and cancer.

  2003cited by this paper
• Telomere dysfunction and the initiation of genome instability

  2003cited by this paper
• Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

  2002cited by this paper
• Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database

  2002cited by this paper
• Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Cellular senescence as a tumor-protection mechanism: the essential role of counting.

  2001cited by this paper
• Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes

  2001cited by this paper
• A critical role for telomeres in suppressing and facilitating carcinogenesis.

  2000cited by this paper
• Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma

  1999cited by this paper
• Single base discrimination of CENP-B repeats on mouse and human Chromosomes with PNA-FISH

  1999cited by this paper
• Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts. A review.

  1997cited by this paper
• The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.

  1996cited by this paper
• Multifactorial analysis of p53 alteration in human cancer: A review

  1994cited by this paper
• Reduction of telomeric length and c‐erbb‐2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters

  1994cited by this paper
• Telomeres shorten during ageing of human fibroblasts

  1990cited by this paper
• Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

  1984cited by this paper

• Aurora B inhibition induces polyploidy and mitotic catastrophe in HER2-amplified breast cancer: Telomere shortening as a potential anticancer mechanism of AZD1152-HQPA.

  2025cites this paper
• Melatonin and Breast Cancer: A Review Article

  2025cites this paper
• Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics

  2025cites this paper
• Obesity-Senescence-Breast Cancer: Clinical Presentation of a Common Unfortunate Cycle.

  2024cites this paper
• Micro-RNAs in breast cancer progression and metastasis: A chromatin and metabolic perspective

  2024cites this paper
• Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer

  2023influential citation
• Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer

  2023cites this paper
• Modulation of Telomerase Gene in Liver Cancer by Natural Compounds

  2022cites this paper
• Assessment of telomerase as drug target in breast cancer

  2020cites this paper
• Long telomeres: A new prognostic factor for severity in triple-negative breast cancer patients

  2020cites this paper
• Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.

  2020cites this paper
• The effect of environmental Bisphenol A exposure on breast cancer associated with obesity.

  2020cites this paper
• Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer

  2020cites this paper
• Telomere lengths differ significantly between small cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.

  2020cites this paper
• Molecular and cellular basis of mammary gland fibrosis and cancer risk

  2018cites this paper
• Clinical relevance of telomerase polymorphism for breast cancer: A systematic review.

  2017cites this paper
• Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma

  2017cites this paper
• Comparison of telomere length and insulin‐like growth factor‐binding protein 7 promoter methylation between breast cancer tissues and adjacent normal tissues in Turkish women

  2017cites this paper
• ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

  2016cites this paper
• Telomere Length and Breast Cancer Prognosis: A Systematic Review

  2016cites this paper
• Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer.

  2016cites this paper
• Telomere shortening in breast cancer correlates with the pathological features of tumor progression.

  2015cites this paper
• Mindfulness‐based cancer recovery and supportive‐expressive therapy maintain telomere length relative to controls in distressed breast cancer survivors

  2015cites this paper
• Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy

  2015cites this paper
• Telomere length alterations unique to invasive lobular carcinoma.

  2015cites this paper
• Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression

  2014cites this paper
• Telomeres in molecular epidemiology studies.

  2014cites this paper
• Telomere shortening distinguishes inverted urothelial neoplasms

  2013cites this paper
• Intratumour Diversity of Chromosome Copy Numbers in Neuroblastoma Mediated by On-Going Chromosome Loss from a Polyploid State

  2013cites this paper
• Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade

  2013cites this paper
• Aurora A nuclear expression and telomere length in BRCA2 related breast cancer

  2013cites this paper
• Function and prognostic value of LAMP3 in cancer

  2013cites this paper
• Telomerase as a useful target in cancer fighting—the breast cancer case

  2013cites this paper
• Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes

  2012cites this paper
• Genetic Variation in Telomere Maintenance Genes, Telomere Length and Breast Cancer Risk

  2012cites this paper
• Cellular Consequences of Telomere Shortening in Histologically Normal Breast Tissues

  2010cites this paper